Abstract

COVID-19 management is becoming a popular topic of research among drug developers, researchers, and scientists because the coronavirus is a rapidly dividing virus that spreads by injecting its genome into the genes of other organisms and multiplying there. As a result, it depends on other organisms for its growth which makes it more challenging to eradicate the disease-causing agent. The Coronaviridae family of viruses includes the enveloped, positive-sense single-stranded RNA virus known as coronaviruses (CoV). Different species of the CoV family cause infections of the upper respiratory tract and gastrointestinal tract in mammals and birds. People typically get the common cold from it, but it can also result in complications such as pneumonia and SARS. The more well-known severe acute respiratory syndrome coronavirus, which in 2003 posed a serious threat with a high mortality rate, is one of the recognized human coronaviruses (HCoV), along with HCoV-229E, -OC43, -NL63, -HKU1, and others. The Middle East respiratory syndrome CoV, a sixth kind of HCoV infection with a high mortality rate, was described by the World Health Organization in 2012. Numerous herbal extracts have been used to treat clinical indications related to the respiratory system as ayurvedic medicine has a treatment for a wide variety of illnesses and complex medical diseases. Therefore, a variety of herbal remedies and purely natural substances can greatly help in the creation of novel antiviral treatments. Tinospora cordifolia, Curcuma longa, Ocimum basilicum, and Allium sativum are a few herbs utilized in COVID-19. In this work, an effort has been made to assess problems and potential treatment with the help of herbal medicine.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call